Jana M Glotzer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Optimizing management of patients with heart failure remains quite challenging despite many significant advances in drug and device therapy for this syndrome. Although a large body of evidence from robust clinical trials supports multiple therapies, utilization of these well-established treatments remains inconsistent and outcomes suboptimal in "real-world"(More)
  • 1